TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Panadact Life Science AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,370
|
1,347
|
1,026 |
Financial expenses |
95
|
1
![]() |
1 |
Earnings before taxes |
156
|
515
|
614 |
EBITDA |
201
|
317
|
-64 |
Total assets |
1,306
|
2,063
|
1,692 |
Current assets |
577
|
1,454
|
1,203 |
Current liabilities |
419
|
1,050
|
637 |
Equity capital |
422
|
647
|
830 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
32.3%
|
31.4%
|
49.1% |
Turnover per employee |
1,370
|
1,347
|
1,026 |
Profit as a percentage of turnover |
11.4%
|
38.2%
|
59.8% |
Return on assets (ROA) |
19.2%
|
25.0%
|
36.3% |
Current ratio |
137.7%
|
138.5%
|
188.9% |
Return on equity (ROE) |
37.0%
|
79.6%
|
74.0% |
Change turnover |
23
|
321
|
-89 |
Change turnover % |
2%
|
31%
|
-8% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.